FDA.reportPublic FDA data

Application 213976

Type
NDA
Sponsor
TAKEDA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EOHILIABUDESONIDESUSPENSION;ORAL2MG/10MLYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
79452ORIG 2024-08-20
78503SUPPL 2024-05-20
78489SUPPL 2024-05-17
77475ORIG 2024-02-12
77465ORIG 2024-02-12